I promised to provide an update on my valuations for SLX based upon nett present value (NPV), I have also done it on the basis of EPS with a P/E ratio of 10. Please do not place too much value on my guestimates - they are based on lots of assumptions and approximations which are almost certainly wrong. I also may have made a typo or an incorrect assumption - please treat them as my musing, DYOR and take them with a large pinch of salt.
I have made the assumption that SLX ends up with 51% of GLE, that the current royalty arrangement is preserved and that SLX/GLE only gets one project (Paducah tails) and all other development (i.e waste processing, Wilmington etc) is NOT valued. As I see it if SLX/GLE does proceed with Paducah tails then it is in the box seat for a lot more but it has to survive to this stage. The difficult period will be financing the pre-development work for Paducah and making a success of phase II and eventually (~2024) Phase III with operational running of Paducah. In terms of
Technology Readiness Level Silex appears to be at about TRL level 5 right now (I disagree with the DoE (Pg 35 of
Tritium & Enriched Uranium Plan to 2060 that GLE are at TRL 3). The objectives are to get to TRL 6 by ~2021 (this is phase II) and with the completion of Paducah tails project TRL 8 by ~2024.
Based upon these objectives and with the assumptions provided below I calculate SLX fair value to be (on both NPV and EPS basis @ P/E 10 to be:
|
Column 1 |
Column 2 |
Column 3 |
Column 4 |
Column 5 |
Column 6 |
Column 7 |
1 |
SLX Share Value estimates (A$) |
|
|
|
|
|
|
2 |
SLX royalty |
7% |
8% |
9% |
10% |
11% |
12% |
3 |
NPV share value (SLX only) |
$0.90 |
$1.00 |
$1.11 |
$1.22 |
$1.33 |
$1.44 |
4 |
NPV share value (GLE only) |
$1.00 |
$0.95 |
$0.91 |
$0.87 |
$0.83 |
$0.79 |
5 |
Combined NPV fair value share price |
$1.90 |
$1.95 |
$2.02 |
$2.09 |
$2.16 |
$2.23 |
6 |
Fair Share Price (on average EPS) |
|
|
|
|
|
|
7 |
P/E multiple for EPS |
10 |
|
|
|
|
|
8 |
EPS share value (SLX only) |
$0.62 |
|
$0.84 |
$0.94 |
$1.05 |
$1.16 |
9 |
EPS share value (GLE only) |
$2.16 |
$2.20 |
$2.25 |
$2.29 |
$2.34 |
$2.38 |
10 |
Combined EPS share price @ P/E multiple |
$2.78 |
$2.20 |
$3.09 |
$3.23 |
$3.39 |
$3.54 |
Assumptions are:
SLX position
|
Column 1 |
Column 2 |
1 |
SLX current Market Cap |
$92,070,000 |
2 |
Current Share Price |
$0.54 |
3 |
No of SLX shares |
170,500,000 |
Exchange Rates
|
Column 1 |
Column 2 |
1 |
Date |
17-Dec-17 |
2 |
US$/A$ |
0.76 |
3 |
GBP/A$ |
0.57 |
GLE position after re-structure
|
Column 1 |
Column 2 |
Column 3 |
Column 4 |
1 |
After re-structure assumed GLE shareholdings |
Cameco |
SLX |
Newco |
2 |
Shareholding in GLE after restructure |
24% |
51% |
25% |
3 |
Assumed re-structure date (after government approvals) |
1-Jan-19 |
|
|
SLX financial position from ann rpts
|
Column 1 |
Column 2 |
Column 3 |
Column 4 |
Column 5 |
1 |
Financial Year |
2016/17 |
2015/16 |
2014/15 |
2013/14 |
2 |
Research and development materials (A$) |
$207,498 |
$60,107 |
$154,296 |
$560,854 |
3 |
SLX Employee benefits expense (A$) |
$3,676,747 |
$3,091,636 |
$4,017,953 |
$5,552,858 |
4 |
GLE Development reimbursement (A$) |
$6,668,102 |
$2,550,261 |
Previously paid by GLE |
|
5 |
Additional contingent liability under PSA (pro-rate to 31/12/2017) |
$2,368,421 |
|
|
|
6 |
Consultants and professional fees |
$914,782 |
$951,041 |
$642,304 |
$817,515 |
7 |
Printing, postage, freight, stationery and communications |
$72,897 |
$99,574 |
$117,893 |
Comms in other |
8 |
Rent, utilities and property outgoings |
$411,461 |
$433,766 |
$474,107 |
$473,459 |
9 |
Net foreign exchange losses |
$155,223 |
$143,418 |
|
$37,665 |
10 |
Other expenses from continuing activities |
$383,912 |
$429,193 |
$595,775 |
$762,300 |
11 |
Total |
$14,859,043 |
$7,758,996 |
$6,002,328 |
$8,204,651 |
SLX consolidated Cash Flow
|
Column 1 |
Column 2 |
Column 3 |
Column 4 |
Column 5 |
Column 6 |
1 |
Year |
2016/17 |
2015/16 |
2014/15 |
2013/14 |
2012/13 |
2 |
Payments to supplier & employees (GST incl) |
$13,496,091 |
$13,157,109 |
$13,835,072 |
$24,718,382 |
$28,773,788 |
3 |
Less est GST rebate |
-$95,382 |
-$97,797 |
-$92,967 |
-$122,006 |
$163,328 |
4 |
Director/KMP remuneration (2016 & 2017 rem rpts) |
$1,670,445 |
$1,189,684 |
$2,151,205 |
$2,344,553 |
|
5 |
Expenses from cash flow (above) |
$5,515,628 |
$5,822,520 |
$5,208,735 |
$6,002,328 |
$8,204,651 |
6 |
Overhead |
$6,214,637 |
$6,047,108 |
$6,382,165 |
$32,943,257 |
$37,141,767 |
7 |
Recurring expenses (less GST) |
$13,496,091 |
$13,157,109 |
$13,835,072 |
$24,718,382 |
$28,773,788 |
8 |
Bank Interest rate received |
2.65% |
|
|
|
|
9 |
Interest 1/7/16 to 30/6/17 |
$1,449,905 |
|
|
|
|
Extra-ordinary 2018 expenditure
|
Column 1 |
Column 2 |
1 |
|
2018 est. |
2 |
PSA contingent payment - pro rata US$1.125m for 15 mnths to 24 months (note 5 (i)) |
$2,368,421 |
3 |
GLE Dev expense for Jul - Dec 2017 - note 7 |
$6,500,000 |
4 |
Total |
$8,868,421 |
|
Column 1 |
Column 2 |
Column 3 |
Column 4 |
1 |
Expected Term Payments |
US$ |
A$ |
Exp. Date |
2 |
Engineering tranche 2 payment |
$5,000,000 |
6,578,947 |
1-Jan-21 |
3 |
Paducah tranche 3 payment |
$15,000,000 |
19,736,842 |
1-Jul-21 |
4 |
Expected Newco welcome payment |
$15,000,000 |
19,736,842 |
1-Jan-19 |
5 |
IQE payment |
$5,000,000 |
$6,578,947.37 |
1-Apr-18 |
|
Column 1 |
Column 2 |
Column 3 |
1 |
Realizable Assets |
30-Jun |
17-Dec |
2 |
No of IQE shares |
6,113,029 |
6,113,029 |
3 |
IQE share price |
£0.175 |
£1.4811 |
4 |
Value (A$) |
$1,876,807 |
$15,884,223 |
5 |
Cash at Bank (30/06/2017) - less current liabilities |
$40,199,069 |
|
|
Column 1 |
Column 2 |
1 |
IQE Revenue (Edison Research) 2018 |
£140,241,000 |
2 |
IQE Revenue A$) |
$246,036,842 |
3 |
IQE growth |
2.36% |
4 |
% cREO products of total |
10% |
5 |
cREO growth rate to 2018 to 2022 |
10% |
6 |
IQE cREO royalty rate (average) |
3.0% |
|
Column 1 |
Column 2 |
Column 3 |
Column 4 |
1 |
Uranum prices/cost |
US$/kg |
A$/Kg |
Ref |
2 |
UF6 price (US$) |
$62.08 |
$82 |
UXC price |
3 |
UF6 Tails costs (US$/kg) |
$1.70 |
$2.24 |
DoE |
4 |
SWU price (US$/SWU) |
$39 |
US$/SWU |
UXC price |
|
Column 1 |
Column 2 |
Column 3 |
1 |
Paducah Tails |
|
|
2 |
Puducah tails tonnes/year |
7,500,000 |
Kg/yr |
3 |
Paducah tails cost (A$) |
$5,007,860 |
/year |
|
Column 1 |
Column 2 |
Column 3 |
1 |
Paducah Revenue/costs |
Amount (A$) |
Unit |
2 |
Paducah full year revenue |
$240,625,347 |
/year |
3 |
SLX royalty income from Paducah (@7%) |
$16,843,774 |
/year |
|
Column 1 |
Column 2 |
Column 3 |
1 |
DCF parameters |
|
|
2 |
Life of Paducah Project |
40 |
yrs |
3 |
Discount rate |
8.50% |
Discount factor (same as PDN) |
4 |
Dividend payout ratio |
0.00% |
|
5 |
Paducah on/off |
1 |
1 on/0 off switch |
|
Column 1 |
Column 2 |
1 |
Construction costs breakdown |
Costs (US$ x106) |
2 |
Site Preparation |
$13 |
3 |
Process Plant |
$252 |
4 |
Process Utilities |
$105 |
5 |
Services |
$133 |
6 |
Infrastructure |
$54 |
7 |
Total Directs |
$557 |
8 |
Indirects, including EPCM |
$145 |
9 |
Owners Costs, including spares and first fills |
$159 |
10 |
Capital Cost, excluding contingency |
$861 |
11 |
Contingency (16% of Directs/Indirects) |
$139 |
12 |
Total |
$1,000 |
|
Column 1 |
Column 2 |
Column 3 |
Column 4 |
Column 5 |
Column 6 |
Column 7 |
Column 8 |
Column 9 |
Column 10 |
Column 11 |
Column 12 |
1 |
Cash Flow/NPV calculations (SLX Only) |
|
|
|
|
|
|
|
|
|
|
|
2 |
Year |
2018 |
2019 |
2020 |
2021 |
2022 |
2023 |
2024 |
2025 |
2063 |
2064 |
Total (A$) |
3 |
Revenue of Excl License holders |
|
|
|
|
|
|
|
|
|
|
|
4 |
GLE Paducah Revenue |
|
|
|
|
|
|
|
$120,312,674 |
$240,625,347 |
$240,625,347 |
$9,504,701,207 |
5 |
IQE cREO/GaN revenue (guess) |
|
|
|
$24,603,684 |
$30,472,956 |
$42,496,267 |
$66,728,098 |
$68,302,692 |
|
|
$1,281,994,123 |
6 |
SLX Income |
|
|
|
|
|
|
|
|
|
|
|
7 |
Paducah Term Income |
|
|
|
$6,578,947 |
|
|
|
$19,736,842 |
|
|
$26,315,789 |
8 |
Paducah Royalty |
|
|
|
|
|
|
|
$8,421,887 |
$16,843,774 |
$16,843,774 |
$665,329,084 |
9 |
IQE Term payment |
|
$6,578,947 |
|
|
|
|
|
|
|
|
$6,578,947 |
10 |
IQE Royalty (est) |
|
|
|
$738,111 |
$914,189 |
$1,274,888 |
$2,001,843 |
$2,049,081 |
|
|
$38,459,824 |
11 |
Dev expense recovery from GLE + overhead (est US$15m) |
$19,736,842 |
|
|
|
|
|
|
|
|
|
|
12 |
Interest income |
$1,449,905 |
$1,237,751 |
$1,087,247 |
$758,413 |
$614,766 |
$333,402 |
$89,904 |
($87,135) |
$24,776,702 |
$25,790,233 |
$447,484,661 |
13 |
Total SLX Revenue |
$21,186,747 |
$7,816,698 |
$1,087,247 |
$8,075,470 |
$1,528,955 |
$1,608,290 |
$2,091,747 |
$30,120,675 |
$41,620,476 |
$42,634,007 |
$1,203,905,148 |
14 |
Cash at bank EoY + IQE shares |
$53,455,623 |
$47,776,230 |
$35,367,387 |
$29,946,767 |
$17,979,631 |
$8,791,048 |
$85,923 |
$23,458,553 |
$974,903,350 |
$1,014,163,335 |
|
15 |
IQE Shares |
$15,884,223 |
|
|
|
|
|
|
|
|
|
$15,884,223 |
16 |
SLX Staff Cost reduction |
100% |
100% |
100% |
100% |
80% |
80% |
50% |
50% |
25% |
25% |
|
17 |
SLX Costs |
$22,364,512 |
$13,496,091 |
$13,496,091 |
$13,496,091 |
$13,496,091 |
$10,796,872 |
$10,796,872 |
$6,748,045 |
$3,374,023 |
$3,374,023 |
$244,375,200 |
18 |
Dividend |
$0 |
$0 |
$0 |
$0 |
$0 |
$0 |
$0 |
$0 |
$0 |
$0 |
$0 |
19 |
Dividend per share |
$0 |
$0 |
$0 |
$0 |
$0 |
$0 |
$0 |
$0 |
$0 |
$0 |
$0 |
20 |
Nett Cash Flow (NCF) |
($1,177,764) |
($5,679,392) |
($12,408,844) |
($5,420,620) |
($11,967,136) |
($9,188,583) |
($8,705,125) |
$23,372,630 |
$38,246,454 |
$39,259,985 |
$959,529,948 |
21 |
Discount factor |
1 |
0.915 |
0.837 |
0.766 |
0.701 |
0.641 |
0.587 |
0.537 |
0.018 |
0.017 |
|
22 |
Nett Present Value (NPV) |
(1,177,764) |
(5,196,644) |
(10,388,994) |
(4,152,525) |
(8,388,312) |
(5,893,238) |
(5,108,596) |
12,550,333 |
702,329 |
659,660 |
83,427,222 |
23 |
Cumulative (incl current cash & shares) |
68,162,081 |
62,965,437 |
52,576,443 |
48,423,918 |
40,035,606 |
34,142,368 |
29,033,771 |
41,584,104 |
152,107,407 |
152,767,068 |
5,035,048,087 |
24 |
EPS |
(0.00) |
(0.02) |
(0.04) |
(0.02) |
(0.04) |
(0.03) |
(0.03) |
0.07 |
0.11 |
0.12 |
|
25 |
SP based upon P/E multiple |
(0.04) |
(0.17) |
(0.37) |
(0.16) |
(0.36) |
(0.27) |
(0.26) |
0.70 |
1.14 |
1.17 |
|
|
Column 1 |
Column 2 |
Column 3 |
1 |
Paducah Parameters |
|
|
2 |
|
|
|
3 |
Urenco Calculator parameters for Paducah |
https://urenco.com/swu-calculator/ |
|
4 |
|
Assumed Assay |
|
5 |
Product assay |
0.711% |
U235 content |
6 |
Tails Assay |
0.100% |
|
7 |
Feed Assay |
0.340% |
|
8 |
Calculator Results |
|
|
9 |
SWU amount/yr |
3,420,070 |
SWU/yr |
10 |
Nat Uranium UF6 product/yr |
2,945,800 |
Kg/yr |
|
Column 1 |
Column 2 |
Column 3 |
Column 4 |
1 |
Cost Parameters |
|
|
|
2 |
|
Amount |
Unit |
Ref |
3 |
US$ Cost/SWU |
$20.00 |
/SWU |
http://www.wise-uranium.org/edumu.html |
4 |
US$/yr Paducah costs |
$68,401,400 |
/year |
|
5 |
Debt amount (US$) |
$1,000,000,000 |
US$ |
CIC rpt (see breakdown below from typical plant) |
6 |
US guarantee loan rate |
4.45% |
% |
US published rates |
7 |
Repayment period |
40 |
years |
SLX announcement |
8 |
Repayments US$/yr |
$53,955,855 |
/year |
Mortgage repayment schedule |
9 |
Sustaining Capital (all years) |
1.5% |
% |
guess |
|
Column 1 |
Column 2 |
Column 3 |
Column 4 |
Column 5 |
Column 6 |
Column 7 |
Column 8 |
Column 9 |
Column 10 |
Column 11 |
Column 12 |
1 |
GLE cash flow |
|
|
|
|
|
|
|
|
|
|
|
2 |
Year |
2018 |
2019 |
2020 |
2021 |
2022 |
2023 |
2024 |
2025 |
2063 |
2064 |
Total |
3 |
Paducah revenue (A$) |
|
|
|
|
|
|
|
$120,312,674 |
$240,625,347 |
$240,625,347 |
$9,504,701,207 |
4 |
AISC costs (A$) |
|
|
|
|
|
|
|
($45,000,921) |
($90,001,842) |
($90,001,842) |
($3,555,072,763) |
5 |
Loan amount (A$) |
|
|
|
|
$407,894,737 |
$434,210,526 |
$473,684,210.32 |
|
|
|
|
6 |
Repayments (A$) |
|
|
|
|
($22,008,309) |
($45,436,510) |
($70,994,546) |
($70,994,546) |
|
|
($2,768,787,297) |
7 |
Sustaining Capital (all years) (A$) |
|
|
|
|
|
|
|
($1,804,690) |
($3,609,380) |
($3,609,380) |
($142,570,518) |
8 |
Stage payment to SLX (A$) |
|
|
|
|
|
|
|
($19,736,842) |
|
|
($19,736,842) |
9 |
SLX stage payments |
|
|
|
|
|
|
|
($19,736,842) |
|
|
|
10 |
SLX royalty (A$) |
|
|
|
|
|
|
|
($8,421,887) |
($16,843,774) |
($16,843,774) |
($665,329,084) |
11 |
Cost of tails (A$) |
|
|
|
|
|
|
|
($2,503,930) |
($5,007,860) |
($5,007,860) |
($197,810,470) |
12 |
Construction Capital Costs (A$) |
|
|
|
|
($372,368,421) |
($355,263,158) |
($367,105,263) |
|
|
|
|
13 |
Nett Cash Flow (NCF) |
|
|
|
|
$13,518,007 |
$33,510,859 |
$35,584,401 |
-$47,886,985 |
$125,162,490 |
$125,162,490 |
$2,356,710,022 |
14 |
Nett Present Value (NPV) |
|
|
|
|
$9,475,389 |
$21,492,702 |
$20,882,680 |
-$25,713,734 |
$2,298,388 |
$2,103,025 |
$333,337,271 |
15 |
EPS |
|
|
|
|
$0.04 |
$0.10 |
$0.11 |
-$0.14 |
$0.37 |
$0.37 |
|
16 |
Combined EPS |
$0.00 |
-$0.02 |
-$0.04 |
-$0.02 |
$0.00 |
$0.07 |
$0.08 |
-$0.07 |
$0.49 |
$0.49 |
|
17 |
SP based upon P/E multiple |
-$0.04 |
-$0.17 |
-$0.37 |
-$0.16 |
$0.05 |
$0.73 |
$0.80 |
-$0.73 |
$4.89 |
$4.92 |
|